{
    "nct_id": "NCT06007690",
    "official_title": "A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma",
    "inclusion_criteria": "* Clinical diagnosis of primary indeterminate lesion or small choroidal melanoma (IL/CM)\n* Have no evidence of metastatic disease confirmed by imaging\n* Be treatment naive for IL/CM (subjects who received PDT may be eligible)\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Have known contraindications or sensitivities to the study drug or laser\n* Active ocular infection or disease",
    "miscellaneous_criteria": ""
}